Pages

Thursday, December 13, 2018

Health Care Reform Articles - December 13, 2018

“Easy to Pay for Something That Costs Less”: New Study Shows Medicare for All Would Save US $5.1 Trillion Over Ten Years

by Jake Johnson - Common Dreams - December 1, 2018

Burlington, VT – Confronting the question most commonly asked of the growing number of Americans who support replacing America’s uniquely inefficient and immoral for-profit healthcare system with Medicare for All—”How do we pay for it?”—a new paper released Friday by researchers at the Political Economy Research Institute (PERI) shows that financing a single-payer system would actually be quite simple, given that it would cost significantly less than the status quo.
“It’s easy to pay for something that costs less,” Robert Pollin, economics professor at the University of Massachusetts Amherst and lead author of the new analysis, declared during a panel discussion at The Sanders Institute Gathering in Burlingon, Vermont, where Pollin unveiled the paper for the first time.
According to the 200-page analysis of Sen. Bernie Sanders’ (I-Vt.) Medicare for All Act of 2017, the researchers found that “based on 2017 US healthcare expenditure figures, the cumulative savings for the first decade operating under Medicare for All would be $5.1 trillion, equal to 2.1 percent of cumulative GDP, without accounting for broader macroeconomic benefits such as increased productivity, greater income equality, and net job creation through lower operating costs for small- and medium-sized businesses.”
The most significant sources of savings from Medicare for All, the researchers found, would come in the areas of pharmaceutical drug costs and administration.
In a statement, Pollin said his research makes abundantly clear that the moral imperative of guaranteeing decent healthcare for all does not at all conflict with the goal of providing cost-effective care.
“The most fundamental goals of Medicare for All are to significantly improve healthcare outcomes for everyone living in the United States while also establishing effective cost controls throughout the healthcare system,” Pollin said. “These two purposes are both achievable.”
As Michael Lighty, a Sanders Institute fellow former director of public policy for National Nurses United, put it during the Gathering on Friday, “We really can get more and pay less.”
The official roll-out of PERI’s analysis came on the heels of a panel discussion of the moral urgency of Medicare for All, particularly during a time when tens of millions of Americans are uninsured, life expectancy is declining, and thousands of families are bankrupted by soaring medical costs each year.
Far from being an unaffordable “pipe dream,” Columbia University professor Jeffrey Sachs—who introduced the panel at The Sanders Institute Gathering on Friday—argued that the PERI study shows Medicare for All “offers a proven and wholly workable way forward.”
“Medicare for All promises a system that is fairer, more efficient, and vastly less expensive than America’s bloated, monopolized, over-priced and under-performing private health insurance system,” Sachs said. “America spends far more on healthcare and gets far less for its money than any other high-income country.”


How 2 New Yorkers Erased $1.5 Million in Medical Debt for Hundreds of Strangers

by Sharon Otterman - NYT - December 5, 2018


If a slim, yellow envelope with a Rye, N.Y., return address lands in your mailbox this holiday season, don’t throw it out. It’s not junk.
Some 1,300 such envelopes have been sent to New Yorkers around the state, containing the good news that R.I.P. Medical Debt, a New York-based nonprofit organization, has purchased their medical debt — and forgiven it.
Last spring, Judith Jones and Carolyn Kenyon, both of Ithaca, N.Y., heard about R.I.P. Medical Debt, which purchases bundles of past-due medical bills and forgives them to help those in need. So the women decided to start a fund-raising campaign of their own to assist people with medical debt in New York.
Over the summer months, the women raised $12,500 and sent it to the debt-forgiveness charity, which then purchased a portfolio of $1.5 million of medical debts on their behalf, for about half a penny on the dollar.

Ms. Jones, 80, a retired chemist, and Ms. Kenyon, 70, a psychoanalyst, are members of the Finger Lakes chapter of the Campaign for New York Health, which supports universal health coverage through passage of the New York Health Act.
“The way sort of opened,” Ms. Jones said. They cast a wide net for donations, she said, explaining to people that the campaign was only a short-term fix for the larger problem of out-of-control medical costs.
Many people take on extra jobs or hours to afford health care, and 11 percent of Americans have turned to charity for relief from medical debts, according to a 2016 poll conducted by The Times and the Kaiser Family Foundation.
The 1,284 New Yorkers who had their debts forgiven live in 40 of the state’s 62 counties, from Westchester to Chautauqua. The sources of the debt were some 130 hospitals and branches that had provided medical services, R.I.P. Medical Debt said.
It has become increasingly easy for regular citizens to purchase bundles of past-due medical bills and forgive them because of the efforts of the debt-relief charity, which was founded in 2014 by two former debt collection industry executives, Craig Antico and Jerry Ashton.

After realizing the crushing impact medical debts were having on millions of Americans, the men decided to flip their mind-set. They began purchasing portfolios of old debts to clear them as a public service, rather than try to hound the debtors.
“I like doing this much more than I liked doing collecting,” Mr. Antico said.
R.I.P. Medical Debt had its first star turn in 2016, when John Oliver did a segment on his HBO show “Last Week Tonight,” in which he paid $60,000 to forgive $14.9 million in medical debts through the charity. About 9,000 people received the yellow forgiveness envelopes as a result.
Since then, other high-profile efforts to forgive debts through the charity include fund-raisers sponsored by NBC and Telemundo affiliates.
In all, the organization says its donations have forgiven $434 million in medical debt so far, assisting some 250,000 people. That remains only a fraction, though, of the more than $750 billion in past-due medical debt that it says Americans owe.
“It is a drop in the bucket,” Mr. Antico said.
R.I.P. Medical Debt specifically seeks to buy the debts of people who earn less than two times the federal poverty level, those in financial hardship and people facing insolvency.
It purchases the portfolios at a steep discount, a penny or less on the dollar. These bills have typically passed through several collection agencies and months or years of collections. The people, who do not know they have been selected, receive the debt relief as a tax-free gift, and it comes off their credit reports.
Mr. Antico said he thought of his charity as a “resolutionary, not a revolutionary” effort, one that offers people relief, but that cannot solve underlying issues like high medical costs. Through personal data associated with the debt accounts, they are able to target specific classes of people, such as veterans, to relieve their debts.

“I do like the idea that people do not have to ask for help,” he said. “The random act of kindness is kind of a cool thing.”
The envelopes from Ms. Jones and Ms. Kenyon’s gift went out in November, but new letters are going out all the time. And don’t worry. Even if you throw your yellow letter out, your debt is still forgiven. You just might not know about it until the next time you run your credit.

A Tough Negotiator Proves Employers Can Bargain Down Health Care Prices

by Marshall Allen - NPR - October 2, 2018

Marilyn Bartlett took a deep breath, drew herself up to her full 5 feet and a smidge, and told the assembled handful of Montana officials that she had a radical strategy to bail out the state's foundering benefit plan for its 30,000 employees and their families.
The officials were listening. Their health plan was going broke, with losses that could top $50 million in just a few years. It needed a savior, but none of the applicants to be its new administrator had wowed them.
Now here was a self-described pushy 64-year-old grandmother interviewing for the job.
Bartlett came with some unique qualifications. She had just spent 13 years on the insurance industry side, first as a controller for a Blue Cross Blue Shield plan, then as the chief financial officer for a company that administered benefits. She was a potent combination of irreverent and nerdy, a certified public accountant whose smart car's license plate reads "DR CR," the Latin abbreviations for "debit" and "credit." 
Most importantly, Bartlett understood something the state officials didn't: the side deals, kickbacks and lucrative clauses that industry players secretly build into medical costs. Everyone, she had observed, was profiting except the employers and workers paying the tab. 
Now, in the twilight of her career, Bartlett wanted to switch teams. In her view, employers should be pushing back against the industry and demanding that it justify its costs. They should ask for itemized bills to determine how prices are set. And they should read the fine print in their contracts to weed out secret deals that work against them. 
The way health care works in America, most employers cede control of costs to their health insurers, the hospitals that treat their employees and the companies they pay to manage their benefits. The costs are a dense thicket that few employers feel equipped to hack through. So they don't.
This failure helps explain why Americans pay the highest health care costs in the world — and why the tab continues to increase, year after year. Employers fund these costs through employee compensation packages, so the math is typically bad news for workers: Rising health costs mean fewer wage increases and less take-home pay. Montana was no different.
And so Bartlett pitched a bold strategy. Step 1: Tell the state's hospitals what the plan would pay. Take it or leave it. Step 2: Demand a full accounting from the company managing drug costs. If it won't reveal any side deals it had with drugmakers, replace it.
Bartlett's strategy would expose a culture in which participants fail to question escalating costs and the role each part of the health care industry plays in them. These little-seen aspects of the health insurance industry and the way Americans pay for medical care are the focus of an ongoing series from ProPublica and NPR. 
As Bartlett laid out her plan that day in July 2014 in a conference room in Helena, Sheila Hogan, then-director of the state's Department of Administration, liked what she was hearing. They needed something radical. To her knowledge, no one had ever tried anything like this. 
Bartlett would be taking on some of the state's power players: hospitals and health insurers — and their politically connected lobbyists. If her plan didn't work, the state and its employees were in trouble. If it did, it could create a blueprint for employers everywhere.
Bartlett knew employers have negotiating power that few of them use. The health care system depends on the revenue produced by the surgeries, mammograms, lab tests and other services it provides, and it can ill afford to lose it. Bartlett got the job. She would call the industry's bluff.
Ballooning medical costs
Employer-sponsored health benefits are almost as old as America itself. In 1798, John Adams, the second U.S. president, signed a law that took 20 cents per month from the paychecks of U.S. seamen to fund their medical care. After the Civil War, lumber, mining and railroad companies in the American West withheld money from employee paychecks to pay for doctors and hospitals.
After World War II, such plans became mainstream. Today, about 150 million Americans get their health benefits through their employers. The industry is dominated by what some call the "BUCAH" plans – Blue Cross Blue Shield, UnitedHealth Group, Cigna, Aetna and Humana. Half a dozen health insurers currently sit near the top of the Fortune 500, with combined annual revenue of about half a trillion dollars. 
Despite the money at stake, many employers have, wittingly or not, deferred to the industry. Decisions about health benefit plans are usually made by midlevel human resources managers who may not understand the forces in the medical industry operating against them. They're often advised by insurance brokers, who are traditionally funded by the industry. And they're trying to keep the peace for employees — who demand convenient access to the care they need. It's a recipe for inertia.
The conventional wisdom is that insurance companies want to reduce health care spending. In reality, insurers' business plans hinge on keeping hospitals and other providers happy — and in their networks — often at the expense of employers and patients. 
Employers often feel caught between rising costs and concern that changes they make will be bad for their employees, says Michael Thompson, president of the National Alliance of Healthcare Purchaser Coalitions, which represents groups of employers who provide benefits to more than 45 million Americans. And, he says, they rely on the advice of industry experts instead of digging into the details.
"We have got to get control of this thing or it's going to bring down the economy, our personal bankrolls and our wages," he says. "It'll cost jobs in the United States and it'll bring down our public programs. This is not a small issue. It's a huge issue."
But Bartlett soon discovered that it was easier to talk about pushing back than to do it. 
A showdown with Montana's hospitals
Bartlett arrived in Helena, the state capital, in fall 2014 as an outsider navigating a minefield of established relationships. From the start, she knew she would have to tackle the staggering bills from the state's hospitals, which made up the largest chunk of the plan's expenses. It wouldn't be popular because they also made up a significant chunk of hospitals' profits
Montana, like many large employers, self-funds its plan. That means it pays the bills and hires an insurance company or other firm to process the claims. More than half of American workers are covered by self-funded plans. As the boss in this arrangement, Bartlett assumed she would have access to detailed information about how much the plan, which was managed by Cigna, paid for procedures at each hospital. But when she asked Cigna for its pricing terms with the hospitals, Cigna refused to provide them. 
Its contracts with hospitals were secret, Cigna representatives told her. That didn't sit well with Bartlett, she recalls. "The payer cannot see the contract," she says, "but we agree to pay whatever the contract says we will pay." 
A cumbersome querying process set up by Cigna allowed her to get individual claims and other limited information. But the company would only give her aggregate data, with things lumped together, to show what she paid each hospital. It was like telling a family trying to reduce its grocery spending that it could only see what it spent in a year, not a breakdown of what bread and fruit and other items cost at each market. 
When Bartlett continued to demand information, Cigna balked; it needed to balance what she wanted with keeping the hospitals happy. "I don't see the need for a balance," she recalls telling them. "I am representing the payer." 
Cigna declined to answer questions about its relationship with Montana's plan, but it said in a statement that it had prioritized the plan's preferences and needs. 
Bartlett ultimately settled on a radical solution: The plan would set its own prices for the hospitals.
In the illusory world of hospital billing, the hospitals typically charge a high price for a procedure, then give insurers in-network discounts. These charges and discounts might be different for each procedure at each hospital, depending on who has more leverage during negotiations. 
The discounts, however, are meaningless if the underlying charges aren't capped. When Bartlett looked at a common knee replacement, with no complications and a one-night hospital stay, she saw that one hospital had charged the plan $25,000, then applied a 7 percent discount. So, the plan paid $23,250. 
A different hospital gave a better discount, 10 percent, but on a sticker price of $115,000. So, the plan got billed $103,500 — more than four times the amount it paid the other hospital for the same operation. Bartlett recalled wondering why anyone would think this was OK. 
Under Bartlett's proposed new strategy, the plan would use the prices set by Medicare as a reference point. Medicare, the federal government's insurance for the disabled and patients over 65, is a good benchmark because it makes its prices public and adjusts them for hospitals based on geography and other factors. Montana's plan would pay hospitals a set percentage above the Medicare amount, a method known as "reference-based pricing," making it impossible for the hospitals to arbitrarily raise their prices. 
Fed up, Bartlett ended the plan's relationship with Cigna. Her battle to upend the status quo riled some employees of her own office, who complained that she was demanding too many changes. Some quit. Bartlett didn't let up. 
That Christmas, the Cigna representative sent each employee in Bartlett's office a small gift, a snow globe. Bartlett didn't get one. 
But her ideas were exciting to Ron Dewsnup, the president of Allegiance Benefit Plan Management, a Montana-based subsidiary of, ironically, Cigna. Allegiance had been studying variation in hospital prices for years and had twice sent reports to Montana hospitals showing how their prices for the same procedures differed significantly. The company had also considered a reference-based pricing model, but it "didn't have any employers that were serious about taking a stand," Dewsnup says. 
Allegiance got the state contract and began by comparing what the plan paid the 11 biggest hospitals in the state with the Medicare rates. The cheaper ones averaged about twice the Medicare rates, the most expensive one about five times the Medicare rates. 
No one wanted to stiff the hospitals, but this was ridiculous, Bartlett recalls thinking. She determined the new rate for all hospitals would be a little more than twice the Medicare rate — still a lucrative deal, but a good starting point to get prices under control. The contracts would also prohibit a practice called "balance billing," under which hospitals bill patients for whatever charges a health plan refuses to pay. 
It would mean a boost for some lower-cost hospitals. Now, she had to persuade the more expensive hospitals to take less. 
"You're in or you're out"
Kirk Bodlovic, the chief financial officer of Providence St. Patrick Hospital in Missoula, remembers the day an entourage from the state health plan, including Bartlett and Hogan, arrived at his hospital. 
Bodlovic knew from Allegiance's reports that St. Patrick's prices were on the high side. But he wasn't prepared for the ultimatum: If St. Patrick's wanted to treat state employees, the hospital would have to accept lower rates. If it didn't, the state would pay for its employees to travel to other hospitals. 
"You're in or you're out, basically," Bodlovic says.
The state's demand set off a series of meetings within the Providence chain, which also operates in California, Alaska and the Northwest. It didn't have a lot of leverage because Missoula is a two-hospital town. Its competitor, one of the lower-priced facilities, had already agreed to the deal. 
St. Patrick's considered rejecting the deal. Bodlovic says that thought gives him heartburn to think about now, envisioning the wrath of doctors if some 3,000 state plan members had ended up at a rival hospital. And the hospital would have lost about $4 million in annual revenue. "That's a good chunk of business," he says.
In their final analysis, he says, St. Patrick's officials decided it was the "lesser pain" to accept the new contract than to be left out of the deal. 
While the state worked to get hospitals to sign new contracts, their CEOs and lobbyists plotted end runs, scheduling meetings with the governor's office to propose alternative solutions. When they arrived for the meetings, they found that Bartlett had also been invited. She effectively blocked their ideas. 
Still, Bartlett had to get all the hospitals on board — or else. The new pricing was set to go live on July 1, 2016, and, with a month to go, six of the major hospitals were holding out. "I started to panic," Bartlett recalls. 
During sleepless nights, Bartlett imagined thousands of state employees being forced to zigzag across the state for medical care or running up massive bills at noncontracted hospitals. She put together communication plans for members describing how they would need to travel to avoid certain hospitals.
With her stomach in knots, she went on the offensive. She took a graph showing the variation in hospital prices to state legislators. Then she threatened to go public. She couldn't name names because of contract restrictions, but she could tell the media that some hospitals' prices were three times as high as others and let reporters figure out which ones were which. 
Five of the holdouts surrendered and signed the contract. "The hospitals didn't want that out there," she says. 
Only Benefis Health System in Great Falls, one of the higher-priced hospitals, refused. The hospital's CEO told the local newspaper that "it was business for them and it was business for us." 
The new plan went into place July 1, without Benefis as a contracted hospital. Bartlett ratcheted up the pressure one more time, calling in the Montana Federation of Public Employees. The union has hundreds of members in the Great Falls area, including Keith Leathers, who works as an investigator with the state's child support enforcement division. 
Leathers has a young daughter with scoliosis, and he didn't want to drive long distances to get her the care she needs. He readily engaged in the fight.
"We have a regional medical facility here that's supposed to be able to handle almost any medical problem, period," he recalls thinking. "And I got to go out of town to get care because they want to charge more than anyone else?"
Union leaders launched a campaign against the hospital. Leathers says he sent a postcard and made a phone call every day to the hospital CEO, the board members — anyone he could find in leadership. He urged them to accept the new rates. Hundreds of other employees from across the state did the same. 
Within a month, Benefis agreed to join the health plan. The hospital declined to comment for this story.
Leathers says employers and workers should be protesting health care costs "over and over again" all over the country. "Are we going to wait until the health care system just crashes?" he says. 
When Bartlett took over the state health plan, it spent about $200 million a year. Bartlett's team estimated that the new hospital pricing schedule saved the plan more than $17 million in the second half of 2016 and all of 2017 — almost $1 million a month. By 2017, a plan that state officials had predicted would go broke had turned itself around. And it's projected to save an additional $15 million in 2018 without cutting benefits to employees or raising their rates. 
Exposing hidden drug deals
But Bartlett had one more target in her sights: prescription drug costs. 
Health plans contract with separate companies, middlemen entities known as pharmacy benefit managers, to get members their medication. And everyone assured Bartlett the state's pharmacy benefits deal was "state of the art." But just like with Cigna, she insisted on examining it herself. That wasn't easy because the pharmacy benefits were run through a cooperative arrangement with other health plans, including those of universities, school trusts and counties. The state plan anchored the co-op, and the other partners were happy with the arrangement.
Bartlett knew that pharmacy benefit managers are notorious for including deals that boost their profits at the expense of employers. One of the common tricks is called the "spread." A pharmacy benefit manager, for example, will tell an employer it cost $100 to fill a prescription that actually cost $60, allowing the pharmacy benefit manager to pocket the extra $40. The fine print in the contracts often allows it. 
The spread is widespread. A recent report by the Ohio state auditor noted that the spread on generic drugs had cost that state's Medicaid plan $208 million in a single year — 31 percent of what it spent.
Sure enough, when she got the contract, Bartlett found that the state plan had fallen victim to the spread. 
Pharmacy benefit managers also rake in dollars through rebates paid by pharmaceutical companies. Most health plans would assume that because they're paying for the drugs, they should get any rebates. But pharmacy benefit managers often don't disclose the size of the rebate, which allows them to keep some or most of it for themselves. When Bartlett pressed, she discovered the state wasn't getting the full amount of its rebates. 
Montana was getting taken, but it put Bartlett in a touchy political situation. The co-op needed the state as a partner or it wouldn't survive. Bartlett decided her allegiance was to the plan's bottom line. She pulled out of the deal. 
"She wasn't afraid of ruining her career or making people angry," says Scott McClave, a consultant with Alliant Insurance Services who helped analyze the pharmacy benefit contract. 
Bartlett says it helped that she was near the end of her career and didn't need to please people. "I'm 67, so I could give a s***," she says. "What are they going to do, fire me? I'm packin' a Medicare card." 
Bartlett found a pharmacy benefit manager, Navitus Health Solutions, that would not take any spread and would pass along all rebates in full. The next year, the plan saved an average of almost $16 per prescription. It purchased a similar mix and volume of drugs in 2016 and 2017. But it saved $2 million on the spread. And its revenue from rebates jumped from $3.5 million to $7 million, Bartlett said. The savings continue to this day.
In July of this year, her mission accomplished, Bartlett left her position as administrator of the state employee health plan. She now works for the office of the Montana insurance commissioner, which is taking on pharmacy benefit managers in a bigger way. 
But Bartlett also has a side gig as a guru to other employers across the country seeking to pay less for their health benefits. Her advice boils down to pushing back. "You've got to get in there and do it," she says. 
So how are Montana's hospitals after the price cut? Just fine, it appears. 
Bob Olsen, vice president of the Montana Hospital Association, says he has not heard hospital leaders say they are struggling under the new state contract. They have had "reasonable financial performance," he says. 
But Bartlett's legacy may be even greater. With the state's model in mind, St. Patrick's Bodlovic said Blue Cross Blue Shield of Montana, the state's largest insurer, recently came calling. Now it wants a similar pricing arrangement. 

ProPublica is a nonprofit newsroom based in New York. Sign up to get ProPublica's Big Story newsletter to receive stories like this one in your inbox as soon as they are published.

Why mixing Medicare with commercial insurance is not the health reform we need

by Diane Archer - Just Care - December 5,. 2018

At a gathering last weekend in Burlington, Vermont, convened by the Sanders Institute, with support from National Nurses United, I spoke about the perils of giving people the choice between Medicare and commercial insurance. We need improved Medicare for all, one single federally administered health plan that meets everyone’s needs.
To maximize profits, commercial health insurers, including Medicare Advantage plans have to steer clear of delivering good affordable care to people who most need care, people with complex or disabling conditions. They don’t compete to deliver better care at lower cost for people with costly needs and never will. It’s not in their financial interest.
Think about it. When was the last time you heard Aetna, or UnitedHealth boast about its great cancer or stroke care or say “Join us if you have heart disease?”
Commercial health insurers too often design their networks so that they don’t include the top cancer center or other centers of excellence in a community. They want to keep people with cancer and other costly conditions from signing up with them. Have you ever heard of a health plan that says if you need costly care, you can use top doctors and hospitals with low costs? That’s the one we all want. That’s Medicare for all. You can’t get that from a commercial health plan.
Here’s why. If a group of people got together to offer the best commercial health insurance, with a robust network of the best hospitals and doctors, they would be out of business before they opened their doors. Everyone needing costly care would join. They couldn’t spread costs across healthy and sick. And, they couldn’t afford to deliver needed care. And, that, in a nutshell is why commercial health insurers will never meet our needs.
There is no way to create a level playing field between commercial insurers and Medicare. Commercial health insurers will always game the system if there is a public option and people have the choice of traditional Medicare. Only if there is a single payer, as with improved Medicare for all, can you pool and broadly distribute costs, rein in spending, and guarantee everyone good coverage.
Commercial health insurers force people to gamble with their health and their savings. If you’ve ever wondered why you have little or no clue what you’ll pay for your care with your health insurance, it’s not your fault. They do not tell you.
Commercial health plans are designed specifically to not meet everyone’s needs. Their narrow networks, arbitrary delays and denials of care and high out-of-pocket costs penalize people who need costly care and keep people from getting needed care.
We need to end systemic bureaucratic waste and profiteering in our health care system. Commercial insurers drive up administrative costs and pocket profits for their shareholders rather than investing in their members’ needs, let alone the public health. They don’t look out for the long-term collective health of Americans.
We need a transparent single-payer health care system so we understand what’s working and what’s not working and the government can drive systemic improvements. Commercial insurers hide their data, claiming it’s proprietary. Their financial incentives are not aligned with the public good.
If you support Medicare for All, please sign this petition to Congress.




But after 18 years living with diabetes, Lautner now says the hardest thing about the diagnosis is accessing insulin — the expensive drug she needs to keep her alive. She's had to borrow money from her parents to pay for insurance; she's spent hours on the phone with drug companies; she's switched brands of insulin to save costs; and she even moved to a new state, Kentucky, with a more generous Medicaid plan.
Last year, Lautner noticed other people with Type 1 diabetes tweeting similar stories under the hashtag #Insulin4All. She read the stories of Shane Patrick Boyle and Alec Raeshawn Smith, two men who died because they could not afford their insulin. It was an epiphany.
"I thought, 'My goodness, there's more people than me. I'm not the only one out here,' " she says.
Since then, Lautner has joined a group of consumer activists, people who need insulin to live and are angry about the sky-high prices. They are putting pressure on the three main companies that make insulin: Sanofi of France, Novo Nordisk of Denmark, and Eli Lilly and Co. in the U.S.
Taking on the drugmakers
The cost of insulin nearly tripled between 2002 and 2013 and has doubled again since then. The list price is over $300 for a single vial of medicine, and most people with Type 1 diabetes need multiple vials every month to live. That cost is typically lower with insurance or with discount programs. Still, for some people the price is unmanageable.
There's been some action by lawmakers on the issue. In October Minnesota's attorney general sued insulin manufacturers alleging price gouging, and a bipartisan caucus in the U.S. Congress issued a report in November urging action to bring insulin prices down.
But prices are still going up, so consumer activists like Lautner are taking things into their own hands.
Nonprofit group T1International, which advocates for Type 1 diabetes around the world, with a particular focus on insulin prices, has started holding rallies outside the Indianapolis headquarters of pharmaceutical giant Eli Lilly and Co. (Eli Lilly and Novo Nordisk have provided financial support to NPR.)
Lautner joined more than 70 people who came together to demonstrate there in September. They were asking for three things: transparency about how much it costs to make a vial of insulin and how much profit comes from each vial, and a commitment from the company to lower the list price of insulin.
There were protesters from at least 12 states, mainly Ohio, Illinois, Indiana and Kentucky, but also from as far away as New York. Lautner, who now lives outside Cincinnati, rented a school bus with a dozen others to make the 112-mile trip.
"Insulin is kind of the face of the drug pricing crisis in America," says Elizabeth Pfiester, founder of T1International and who has Type 1 diabetes herself. "We literally die without it," she says. "We're fighting for our lives."
This was the third time the group had protested at Eli Lilly headquarters. Last fall, when the group held its first protest there, Pfiester says, as it was "the first time where people living with Type 1 were able to physically stand and show that people are angry enough to come out."
If you can't afford your insulin
The companies that make insulin offer resources for people having difficulty affording insulin. You can find more information here:
While there are cheaper versions of insulin available over-the-counter, they work differently than most insulin prescribed by doctors, and it can be difficult to guess at the right dosage and timing. If you are considering using an over-the-counter insulin you should consult with your health care provider.
Eli Lilly declined NPR's request for an interview, but in statement a spokesperson said, "we understand why people are making their voices heard."
Protesting is one arm of their advocacy efforts; the group is also lobbying at the state and national level, and conducting online awareness-raising campaigns under the hashtag #Insulin4All.
Advocacy at the state level
Last spring, the fight got even more personal for Angela Lautner. She got a letter from her insurance company stating they were no longer going to pay for the insulin she was taking. They wanted to switch her to a different brand.
Most people with Type 1 diabetes use two types of insulin: short-acting insulin to counteract the carbohydrates consumed with meals, and long-acting insulin to keep blood sugar stable throughout the day.
Lautner has found that the long-lasting insulin brand Lantus works best with her body; it keeps her blood sugars low, but not so low that she becomes dangerously hypoglycemic, risking death. But her insurer was dropping its coverage of Lantus in favor of a different long-lasting insulin, Basaglar.
"The problem that I immediately saw was that [Basaglar] had not worked for my body," Lautner says. "So I go into my doctor's office with this letter and I'm like, 'What am I going to do?' "
Lautner's doctor connected her to Sanofi's drug discount program, where she was able to get a month's supply of Lantus for a couple of hundred dollars. So she decided to pay for the insulin herself.
"I'm fortunate enough to have an emergency fund," Lautner says.
But she knows others aren't so lucky.
This year, Lautner organized her own group of diabetes activists in Kentucky, Ohio and Indiana, called KOI Insulin4All. They've met with legislators in all three states about establishing emergency insulin prescription refills and about making the cost of insulin more transparent.
There are similar groups starting up in Oklahoma, Pennsylvania, Minnesota and Illinois. In November, activists protested outside the Cambridge, Mass., office of Sanofi. All of them are pushing for the same thing — to make the voices of people with diabetes heard.





Tuesday, December 4, 2018

Health Care Reform Articles -December 4, 2018

What Do The Midterms Mean For Medicare For All?

by Sanjay Kishore, Micah Johnson and Don Berwick - Health Affairs - December 3, 2018

Health care was the most important issue for voters in the 2018 Congressional elections, in which Democrats won a significant majority in the US House of Representatives. A major health care proposal supported by many Democrats is “Medicare for All”, which would create a publicly-financed, single-payer health insurance system for all Americans.
Many observers dismiss single-payer health care as a political non-starter , but this traditional view ignores an explosion of support for the idea in recent years. In one recent poll, over 70 percent of Americans said they would support “a policy of Medicare for All”, including 85 percent of Democrats and even 52 percent of Republicans. A subsequent poll asked “do you support providing Medicare for every American” and found nearly identical results, including majorities of support from respondents in the South, those who live in rural areas, and those who say they “lean conservative.”
Political leaders are responding to this surge. In 2017, 17 Senators and 124 Representatives sponsored or co-sponsored Medicare for All bills. In 2018, the Congressional “Medicare For All Caucus” launched, which had 76 members as of August 2018. Most of the likely Democratic contenders for President in 2020 have also announced their support. Even Barack Obama, who eschewed single-payer in favor of the Affordable Care Act during his Presidency, has now endorsed Medicare for All.
What insights do the 2018 elections provide into the future political prospects of Medicare for All?

House Of Representatives

In the 2018 elections, Democrats regained a majority in the House of Representatives, winning almost 40 seats back from Republican control in the biggest pickup for Democrats since the post-Watergate elections in 1974.
We analyzed the campaign platforms, bill co-sponsorship records, and public statements of the newly elected members of Congress, and found that the number of Representatives supporting Medicare for All has risen to at least 133, now representing almost 60 percent of the Democratic Congressional delegation (Figure 1).
These supporters include over 100 incumbent co-sponsors of H.R.676 who won re-election (H.R.676 is the Medicare for All bill in the House). There are also many new political faces who support Medicare for All, including progressive newcomers Alexandria Ocasio-Cortez (NY-14), Ayanna Pressley (MA-07), Rashida Tlaib (MI-13), Ilhan Omar (MN-5), and Jahana Hayes (CT-2). Medicare for All supporters also won elections in swing Congressional districts and traditionally conservative states. California’s 48th district has elected a Republican Congressman for nearly 30 years; Harley Rouda narrowly defeated the incumbent this year, calling for health care as a right and pursuing “Medicare for All as a long-term solution.” Sylvia Garcia is a first-time candidate who won election in Texas by promising, “I will fight for Medicare for All."
There are also a number of Representatives who have not explicitly declared their support for Medicare for All, but have signaled that they remain open to the idea. Joe Kennedy (MA-04), a rising star in the Democratic Party, did not co-sponsor H.R.676; however, he has said he would consider co-sponsoring an updated version of a Medicare for All bill if it addressed his concerns with the current version.

Senate

In the 2018 elections, Democrats lost seats in the Senate, leaving them with a total of 47 seats.
We analyzed campaign platforms, bill co-sponsorship records, and public comments made by both incumbent and newly elected Senators, and found that at least 16 Democratic Senators support Medicare for All in the upcoming Congress (Figure 2).  This count does not include Senators who have indicated an openness to Medicare for All without issuing their support—for instance, centrist Montana Senator Jon Tester has said Congress should take a “solid look” at single payer. Compared to the House, relatively few new political faces entered the Senate this year; newcomers Kyrsten Sinema (AZ) and Jacky Rosen (NV) did not explicitly support Medicare for All.  States with two Senators who support Medicare for All include Massachusetts, Vermont, New Mexico, and Hawaii. 

Implications For The 116th Congress

Medicare for All will not become law in the next two years, but the incoming 116th Congress could play an important role in determining the future of the proposed reform.
First, this Congress will have an opportunity to distinguish Medicare for All from other Democratic proposals to expand public coverage. To capitalize on the popularity of Medicare for All, some organizations have released more moderate proposals with sound-alike names such as “Medicare Extra for All”; others have started to brand Medicare buy-in proposals with slogans like “Medicare Available to All” or “Medicare for Anyone.” These alternatives are essentially variations on a public option. These proposals vary in their details and scope, and their relative merits are worthy of debate in the upcoming Congress. However, they differ substantially from the actual Medicare for All bills that have been proposed in Congress for many years. The 116th Congress will have an opportunity to clarify these differences, and to build further public understanding of Medicare for All.
Second, the 116th Congress can start building consensus on key policy elements of a Medicare for All proposal, including knotty issues such as determining the covered benefits of the plan, exploring alternative revenue sources and cost controls, deciding how providers would be paid and at what prices, how to pave a practical transition pathway from current health plans, how to craft a soft landing for the employees of the current insurance industry, and more. Ideally, this exploration will help foster a deeper and more mature discussion of Medicare for All among legislators in the future.
The legislative process provides a roadmap by which policy consensus can be pursued. Rep. Pramila Jayapal (WA-7), co-chair of the Medicare for All Caucus, will become the primary sponsor of the House Medicare for All bill, and a revised version of the bill will almost certainly be released early in the Congressional session. The bill will then fall to two key committees with relevant jurisdiction: Ways and Means, and Energy and Commerce. These committees have the opportunity to “mark up” the bill and hold public hearings. The degree to which Medicare for All receives hearings—and whether it is ultimately voted out of committee—will depend heavily on the degree of support from the leadership and membership on these two committees.
On the Energy and Commerce Committee, incoming Chairman Frank Pallone (NJ-6) has said he has “always been an advocate for Medicare for All or single payer”, but he has not co-sponsored H.R.676 and has said that his priority as Chairman will be to stabilize the Affordable Care Act. The member most likely to head the Health Subcommittee of Energy and Commerce is Anna Eshoo (CA-18), a co-sponsor of H.R.676 and supporter of Medicare for All.  On the Ways and Means Committee, neither the incoming Chairman (Richard Neal, MA-1), nor the favorite to head its Health Subcommittee (Lloyd Doggett, TX-35), have indicated support for Medicare for All. Additionally, the likely Chair of the Budget Committee (John Yarmuth, KY-3) has stated that he plans to hold hearings on Medicare for All.
Though these procedural machinations don’t often make headlines, House committees have a critical opportunity to raise national awareness of Medicare for All, bring stakeholders to the table, and work toward consensus on policy details—if the powerful members of these committees choose to do so.
Finally, it is possible that the 116th Congress could bring Medicare for All to a vote on the floor of the US House of Representatives. To pass the House, an additional 85 members of Congress would need to join the 133 supporters we have identified to compose a 218-vote majority. If Medicare for All passes the House, it would be a powerful symbolic step showing that Congress is serious about pursuing this reform, and underlining its widespread support. Even if Medicare for All does not pass the House, a vote would force Representatives to officially declare their positions. Holdouts may face increased pressure during the 2020 elections, especially if public support for Medicare for All continues to grow.

Implications For 2020 Elections And Beyond

Passage of Medicare for All will remain highly implausible without Democratic control of the Presidency and both chambers of Congress. Even if Democrats regain the Presidency in 2020 and retain a majority in the House, the loss of Senate seats in the 2018 midterms make the prospect of united government in 2020 more difficult. In 2020, 33 Senate seats will be up for election, and Democrats must regain at least four of them to win a majority. The most likely path towards a Senate majority would involve winning elections in four states currently controlled by Republicans: Maine, North Carolina, Iowa, and Arizona. Democrats would also need to hold their current seats in states like Michigan, Alabama, and Virginia. In short, Democratic control of the Senate, House, and Presidency in 2020 remains highly uncertain.
Furthermore, history has shown that even a unified government does not guarantee the success of comprehensive health reform. Supporters must contend with intra-party disagreements, attempts at filibuster in the Senate, and garnering the support of key and powerful stakeholders in the health care industry. But these are obstacles faced by any meaningful health reform, not just Medicare for All.
It is time to re-frame the public debate: the path to Medicare for All is difficult, not impossible. In a democracy, it is strange and basically untenable to insist that an idea at least nominally supported by 70 percent of the citizenry is not even worthy of serious consideration. Medicare for All, though difficult, is now within the realm of political possibility, and the surge of enthusiasm among new members in the House of Representatives is evidence of renewed public interest in expanding access to health coverage and controlling costs.
As Presidential contenders enter the 2020 primaries, Medicare for All will almost certainly become a focal point of national discourse. Instead of pretending that Medicare for All is impossible, health policy experts and Congressional leaders should deepen their knowledge of the promise and challenges of single-payer health reform, and start working seriously on the hard job of crafting the best possible version of Medicare for All.

Health care industry is geared up to fight Medicare for All

by Diane Archer - JustCare - November 28, 2018

With momentum for Medicare for all growing, the Intercept reports that the health care industry is already geared up to fight it. Medicare for all’s biggest opponents are the insurance and pharmaceutical industries, and the businesses they contract with, including the Council of Insurance Agents and Brokers. These businesses have a lot to lose financially when Medicare for All becomes law.
Make no mistake. Health care corporations are responsible for driving health care costs up and jeopardizing people’s health and financial well-being. As corporations, they are legally required to put their shareholders’ profits ahead of people’s health care needs.
Government-administered insurance, Medicare, is less expensive, more equitable, and better ready to meet your needs than corporate commercial insurance. Ask anyone with traditional Medicare. The government lets your doctors decide the care you need. Commercial insurers tell you which doctors you can see and tell those doctors what care they will cover, often wrongly denying needed care to enhance their profits.
Not surprisingly, Americans are far more satisfied with Medicare than with commercial health insurance. That’s one reason why Medicare has survived more than 50 years of attacks by Republicans and conservative Democrats alike.
Medicare for all offers better care at less cost than traditional Medicare, with coverage of dental, hearing and vision care and with no premiums, coinsurance or deductibles. Given how difficult it can be to get needed care today in our commercial health insurance system, opponents of Medicare for all face a serious challenge.
Today, seven in ten Americans support Medicare for all.  A total of 123 House Democrats have co-sponsored Medicare for All legislation. And, 48 new members of Congress campaigned to support it.
Medicare for all’s opponents have formed the “Partnership for America’s Health Care Future.”  They are trying to undermine Medicare for all through campaign contributions to, and talking points for, Democratic candidates who have pledged to oppose it. The talking points are designed to scare people by focusing on the cost of Medicare for all. In truth, the talking points bury the lede.
Medicare for all reduces overall health care costs while guaranteeing everyone coverage. It saves $2 trillion over ten years, by conservative estimates, and lets people see the doctors they know and trust anywhere in America with no premiums, copays or deductibles. Not surprisingly, many of the Democrats who opposed Medicare for all lost in the midterms, including Bill Nelson, Joe Donnelly and Danny O’Connor (D-OH).
The Democrats will need a Democratic majority in the House and Senate, along with a Democratic President to pass Medicare for all. But, that could be just two years away. To succeed, the public needs to be ready to respond to the Partnership’s key talking points. They claim that Medicare for all would mean “ripping apart our current system.” In truth, Americans would not feel even a small tear, as they would continue to be able to see the doctors and use the hospitals they know and trust.
Opponents will also emphasize that Medicare for all would mean the end of employer-based coverage, tax increases and greater government control over the health care system. In fact, people would see higher wages, wages that had formerly gone to paying for their health care, and still be able to see the doctors they know and trust. They would pay less overall for their care and would have no out-of-pocket costs for their care. Moreover, Medicare for all would displace the insurance company bureaucrats who tend to offer poor provider networks and get between patients and their doctors. These bureaucrats’ big skill is in knowing how to keep people from getting care when they need it.
Truly, if commercial health plans are really smart innovators, why has not one of them ever spoken out about the ways they select their network providers or how they deliver high-value care?
Today, many people can no longer afford to see the doctor or to fill their prescriptions. Some die. We rank lower than people in most other developed countries on life expectancy, infant mortality and more. Medicare for all will bring us better care.  The right politics and the right policy is to end the horrors of our commercial health care system. In fact, it is the only positive and viable solution.
If you support Medicare for all, please sign this petition to Congress.
http://justcareusa.org/health-care-industry-is-geared-up-to-fight-medicare-for-all/?

'Easy to pay for something that costs less': New study shows 'Medicare for All' would save US $5.1 trillion over 10 years

by Jake Johnson - Common Dreams - December 1,2018

Confronting the question most commonly asked of the growing number of Americans who support replacing America's uniquely inefficient and immoral for-profit healthcare system with Medicare for All—"How do we pay for it?"—a new paper released Friday by researchers at the Political Economy Research Institute (PERI) shows that financing a single-payer system would actually be quite simple, given that it would cost significantly less than the status quo.
"We really can get more and pay less."
—Michael Lighty
"It's easy to pay for something that costs less," Robert Pollin, economics professor at the University of Massachusetts Amherst and lead author of the new analysis, declared during a panel discussion at The Sanders Institute Gathering in Burlingon, Vermont, where Pollin unveiled the paper for the first time.
According to the 200-page analysis (pdf) of Sen. Bernie Sanders' (I-Vt.) Medicare for All Act of 2017, the researchers found that "based on 2017 U.S. healthcare expenditure figures, the cumulative savings for the first decade operating under Medicare for All would be $5.1 trillion, equal to 2.1 percent of cumulative GDP, without accounting for broader macroeconomic benefits such as increased productivity, greater income equality, and net job creation through lower operating costs for small- and medium-sized businesses."

The most significant sources of savings from Medicare for All, the researchers found, would come in the areas of pharmaceutical drug costs and administration.
In a statement, Pollin said his research makes abundantly clear that the moral imperative of guaranteeing decent healthcare for all does not at all conflict with the goal of providing cost-effective care.
"The most fundamental goals of Medicare for All are to significantly improve healthcare outcomes for everyone living in the United States while also establishing effective cost controls throughout the healthcare system," Pollin said. "These two purposes are both achievable."
"Medicare for All promises a system that is fairer, more efficient, and vastly less expensive than America's bloated, monopolized, over-priced and under-performing private health insurance system."
—Jeffrey Sachs, Columbia University
As Michael Lighty, former director of public policy for National Nurses United, put it during The Sanders Institute Gathering on Friday, "We really can get more and pay less."
The official roll-out of PERI's analysis came on the heels of a panel discussion of the moral urgency of Medicare for All, particularly during a time when tens of millions of Americans are uninsured, life expectancy is declining, and thousands of families are bankrupted by soaring medical costs each year.
Far from being an unaffordable "pipe dream," Columbia University professor Jeffrey Sachs—who introduced the panel at The Sanders Institute Gathering on Friday—argued that the PERI study shows Medicare for All "offers a proven and wholly workable way forward."
"Medicare for All promises a system that is fairer, more efficient, and vastly less expensive than America's bloated, monopolized, over-priced and under-performing private health insurance system," Sachs said. "America spends far more on healthcare and gets far less for its money than any other high-income country."
Watch the full discussion of the new paper between Pollin and Lighty at The Sanders Institute Gathering below:
https://www.alternet.org/easy-pay-something-costs-less-new-study-shows-medicare-all-would-save-us-51-trillion-over-10-years?src=newsletter1098331

Ocasio-Cortez: 'Frustrating' that lawmakers oppose Medicare-for-All while enjoying cheap government insurance

by John Bowden - The Hill - December 1, 2018

Incoming Rep. Alexandria Ocasio-Cortez (D-N.Y.) tweeted Saturday that she was frustrated to learn that her health-care costs would be chopped by more than half upon entering Congress, accusing her fellow lawmakers of enjoying cheap government health insurance while opposing similar coverage for all Americans.
In a tweet, the New York freshman lawmaker-elect wrote that her health care as a waitress was "more than TWICE" as high as what she would pay upon taking office as a congresswoman next month.
"In my on-boarding to Congress, I get to pick my insurance plan. As a waitress, I had to pay more than TWICE what I’d pay as a member of Congress," Ocasio-Cortez wrote Saturday afternoon.
"It’s frustrating that Congressmembers would deny other people affordability that they themselves enjoy. Time for #MedicareForAll," she added.

Trump’s Budget Director Reveals Plans to Attack Social Security and Medicare

by Nancy Altman - Common Dreams - December 1, 2018
Opponents of Social Security and Medicare are so eager to end these two overwhelmingly important and popular earned benefits that they can’t contain themselves. Mick Mulvaney, the Trump administration’s director of the Office of Management and Budget, is the latest to make crystal clear the longstanding plan to destroy both programs.

Speaking at a conference of state legislators hosted by the anti-government American Legislative Exchange Council (“ALEC”), Mulvaney just revealed that he plans first to go after what he sees as more politically achievable cuts. He explained that the next step, presumably after Trump is in his second term, will be for the administration not just to cut these programs but to end them as we know them.

Mulvaney is apparently so eager to go after our earned benefits that he threw the point into a speech to state legislators, even though both Social Security and Medicare are federal programs.

Mulvaney’s apparent uncontained enthusiasm to take away people’s earned benefits is similar to that of Mitch McConnell, who just weeks before the midterm, called for Social Security and Medicare to be “adjusted” (code for destroying them). McConnell couldn’t resist broadcasting his intentions, even though these programs are extremely popular even with Republican voters.

Why are these opponents so hostile to such important programs? Social Security, now more than eight decades old, and Medicare, now more than five decades old, have stood the test of time. Both of these efficient, virtually universal, overwhelmingly popular programs insure us against risks that all of us face. Rich or poor, anyone can suffer a disabling illness or accident, making work impossible. Rich or poor, any parent can die prematurely leaving dependent children. Rich or poor, all of us hope to live to old age and, if we are so fortunate, require income we cannot outlive and health insurance for the treatments and medication we inevitably will need.

The private sector is incapable of providing the wage and health insurance that Social Security and Medicare provide as efficiently, universally, securely or effectively as the federal government. Insurance works best when the greatest numbers of people are covered. The only entity that can require that everyone is covered and pays premiums as soon as they start working is the federal government. That is one of the reasons both Social Security and Medicare work so well.

And that is why Mulvaney, McConnell, and other opponents of these programs want to end them. These programs put the lie to their ideological zealotry, which insists that the private sector is always better than government.
Decades ago, opponents of these programs were forthright that their objections were ideological. They did not see the creation and administration of universal insurance programs as an appropriate role for the federal government. But the American people overwhelmingly disagreed, so this argument was utterly unsuccessful.
Now most opponents have changed their tactics, and proclaim their love for these programs. President George W. Bush, for example, proclaimed, “Social Security was a great moral success of the 20th century, and we must honor its great purposes in this new century.” His very next sentence argued for radically changing it. 
Similarly, Mulvaney, McConnell, and other opponents hide their straightforward ideological opposition. Rather, these opponents subversively seek to undermine confidence in Social Security’s and Medicare’s future by asserting that both programs are unaffordable.
Worse, in their efforts to end Social Security and Medicare, they seek to turn Americans against each other. They tell us that seniors are taking from children, that people with disabilities are taking from seniors.
Moreover, in their efforts to lull us into thinking they are not seeking to hurt our legitimate interests, opponents claim that our vital and earned financial protection in the event of disability isn’t as “core” as our financial protection in the event of old age. In his recent ALEC speech, Mulvaney tried to make just such a claim, asserting, “You can reform and save a ton of money in Medicare and Social Security and not touch the primary pillars for the next several years.” Along those same lines, last April, Mulvaney rhetorically asked, “Do you really think that Social Security disability insurance is part of what people think of when they think of Social Security?”
I am confident that the over 10 million Americans receiving Social Security because of wages lost as the result of serious, work-ending disabilities understand that Social Security disability insurance is Social Security. When American workers pay into Social Security with every paycheck, disability insurance is one of the protections they earn, along with life insurance and retirement annuities.
Social Security disability benefits are inextricably intertwined with Social Security’s retirement and survivor benefits. Social Security benefits are generated from the same formula. When workers with disabilities reach retirement age, their benefit is unchanged in amount but is paid as a retirement benefit, no longer as a disability benefit. Despite those facts, though, Mulvaney’s claim that Social Security disability insurance is not really Social Security is a convenient rhetorical game to claim “core” benefits are not being touched.
For Medicare, Mulvaney revealed another trick before his ALEC audience. He floated the idea of Medicare no longer reimbursing teaching hospitals its fair share of those hospitals’ costs, arguing that the cut wouldn’t hurt beneficiaries. Like his claim that Social Security disability insurance is not “really’ Social Security, beneficiaries would be hurt, though not immediately, and the cause of the hurt would be difficult to trace.
While benefits wouldn’t be directly cut, it certainly would limit the ability of Medicare beneficiaries to get treatment at teaching hospitals if that were their choice and the best setting for their care. To the extent Medicare didn’t pay its fair share and teaching hospitals nevertheless continued to treat seniors and people with disabilities, those costs would be shifted to everyone else.
And, of course, this is just the start, Mulvaney made clear. “In the long term you’ll have to [make more major changes.] The president has asked me to fix the easy stuff first,” Mulvaney explained to his audience.
Fortunately, the Democrats—who support expanding, not cutting, Social Security and Medicare—have control of the House of Representatives, at least for now. But, all of us who want to keep the benefits we have earned must remain vigilant. We must not be fooled or confused into allowing opponents to make what they deem “easy” cuts to our earned benefits.
These opponents will not give up. And neither must we. Expanding, not cutting, our Social Security and Medicare is profoundly wise policy and is overwhelmingly popular. But it will only become a reality if we keep our voices loud, reminding our political leaders that it’s voters, not donors, to whom they must account next election day.

Trump administration e-mail plugs private Medicare plans

The Boston Globe - December 1, 2018

WASHINGTON — Older Americans have been flocking to Medicare’s private plans, which promise predictable costs and extra benefits.
But the private Medicare Advantage plans have also been getting an unpublicized boost from the Trump administration, which has in the last few weeks extolled the virtues of the private plans in e-mails sent to millions of beneficiaries.
Medicare’s annual open enrollment period closes Friday. Administration officials predict that almost 37 percent of the 60 million Medicare beneficiaries will be in Medicare Advantage plans next year, up from 28 percent five years ago.
Advertisement
The officials deny that they are steering patients to private plans, but the subject lines of recent e-mails read almost like advertisements. “Get more benefits for your money,” says a message dated Oct. 25. “See if you can save money with Medicare Advantage,” said another sent a week later.
The messages — “paid for by the U.S. Department of Health and Human Services” — urge beneficiaries to “check out Medicare Advantage” and point to an online tool, the Medicare plan finder, to compare the different options.
“You may be able to lower your out-of-pocket costs while getting extra benefits, like vision, hearing, dental and prescription coverage,” said an e-mail sent to beneficiaries on Wednesday.
“With Medicare Advantage,” says another e-mail, “one plan covers all of your care.”
In small print, the e-mails say they were “created and distributed by the Centers for Medicare and Medicaid Services” to people who “signed up for email updates from the Medicare team.”
Seema Verma, the administrator of the Centers for Medicare and Medicaid Services, said the agency was not favoring private plans over the original government-run Medicare program.
“We are not steering any Medicare beneficiary anywhere,” she said.
But Richard S. Foster, who was for many years the nonpartisan chief actuary of the Medicare program, said the emails sounded “more like Medicare Advantage plan advertising than objective information from a public agency.”
“The statements made in the e-mails are generally accurate, but they are one-sided,” Foster said. “The advantages of MA plans are emphasized, while the disadvantages are not mentioned.”
For example, he said, private plans generally require beneficiaries to use a defined network of health care providers or pay more for care outside the network. By contrast, in traditional Medicare, beneficiaries can go to any doctor who accepts Medicare, as most doctors do.
Jo Murphy, who has counseled thousands of Medicare beneficiaries as the director of Michigan’s Health Insurance Assistance Program, said: “It seems that there are a whole lot of promotional e-mails coming from the federal government. There does seem to be encouragement to go to Medicare Advantage, part of a trend favoring private companies over traditional Medicare, for whatever reason.”
Federal spending on Medicare Advantage will nearly triple in the coming decade, to $584 billion in 2028, from $210 billion this year, the Congressional Budget Office estimates.
Insurance executives and investors are also bullish on the outlook for the private Medicare plans, offered by companies like UnitedHealth and Humana, which do extensive marketing of their own at this time of year.
When Congress passed the Affordable Care Act in 2010, it helped offset the cost by cutting payments to Medicare Advantage plans. The CBO and other experts predicted that enrollment in the plans would decline. Instead, it has surged to more than 20 million today, from 11 million in 2010.
Democratic members of Congress from Connecticut recently sent a letter to the administration expressing concern that officials were “inappropriately working to steer Medicare beneficiaries to Medicare Advantage plans.” The agency has an obligation to “provide beneficiaries with accurate information from a neutral, balanced perspective,” said the letter, signed by Senators Richard Blumenthal and Christopher S. Murphy and Representative Rosa DeLauro, among others.
Even without encouragement from the government, Medicare beneficiaries might be gravitating to private plans.
Many people have become accustomed to managed care plans through their employment. When they reach age 65, they are comfortable opting for a private plan — in some cases, a Medicare Advantage plan offered by the same company that provided their employer-based coverage.
Writing this past week in The New England Journal of Medicine, Patricia H. Neuman and Gretchen A. Jacobson of the Kaiser Family Foundation pointed to other possible attractions.
Medicare Advantage plans offer a variety of extra benefits like dental care and gym memberships, they said. Private plans protect against catastrophic health care costs, with an annual limit on out-of-pocket spending for doctors’ services and hospital care. In addition, they said, private plans “offer the convenience of one-stop shopping for all their coverage.”
By contrast, beneficiaries in traditional Medicare typically pay one premium for coverage of doctors’ services, another premium for drug coverage and often a third premium for supplemental insurance like a Medigap policy or a retiree health plan.
Ann E. Mason, 77, of Rochester, N.Y., said she was “very, very satisfied” with her Medicare Advantage plan. The plan, offered by the local Blue Cross and Blue Shield company, has a network of providers, but most local doctors are in it, she said.
Private plans boast of providing superior-quality care, but the evidence is mixed. Researchers have found that patients in poor health are somewhat more likely than others to disenroll from Medicare Advantage and switch to traditional Medicare.
John J. McAuliffe, 77, and his wife, Ann, 78, were in a Medicare Advantage plan and were generally satisfied with it until she had a severe stroke in Charlotte, N.C., in 2017. After a few months, the insurer refused to pay for further care, and the couple challenged the denial through several levels of appeal until they finally prevailed in a hearing before an administrative law judge.
“We went back to traditional Medicare, with a Medigap supplement policy, and it’s been excellent,” John McAuliffe said. “Everything is paid for.”
https://www.bostonglobe.com/news/nation/2018/12/01/trump-administration-mail-plugs-private-medicare-plans/mz2lFjzIFMbCoVRzg9UZ7N/story.html?

U.S. Life Expectancy Drops for Third Year in a Row, Reflecting Rising Drug Overdoses, Suicides
by Meilan Solly - Smithsonian.com - December 3, 2019


On average, life expectancy across the globe is steadily ticking upward—but the same can’t be said for the United States. Three reports newly published by the Centers for Disease Control and Prevention highlight a worrying downward trend in Americans’ average life expectancy, with the country’s ongoing drug crisis and climbing suicide rates contributing to a third straight year of decline.

Related Content

As Lenny Bernstein notes for The Washington Post, the three-year drop represents the longest sustained decline in expected lifespan since the tumultuous period of 1915 to 1918. Then, the decrease could be at least partially attributed to World War I and the devastating 1918 influenza pandemic. Now, the drivers are drug overdoses, which claimed 70,237 lives in 2017, and suicides, which numbered more than 47,000 over the same period. Both of these figures rose between 2016 and 2017.
“Life expectancy gives us a snapshot of the Nation’s overall health,” CDC Director Robert R. Redfield said in a statement, “and these sobering statistics are a wakeup call that we are losing too many Americans, too early and too often, to conditions that are preventable.”
According to Ars Technica’s Beth Mole, 2015 marked the first recorded drop in U.S. life expectancy since 1993, with Americans shaving an average of 0.1 years off of their lifespans. The same proved true in 2016 and 2017, Cathleen O’Grady writes in a separate Ars Technica piece, making the latest projection 78.6 years, down 0.3 years from 2015’s 78.8. Broken down by gender, men could expect to live an average of 76.1 years, down from 76.2 in 2016, while women could anticipate living until 81.1, the same age projected in 2016.
Although the country’s aging Baby Boomer population factored into the decline, Mike Stobbe of the Associated Press reports that increased deaths amongst younger and middle-aged individuals (particularly those between 24 and 44) had an outsized effect on calculations.
As Kathryn McHugh of Harvard Medical School tells NPR’s Richard Harris, “We're seeing the drop in life expectancy not because we're hitting a cap [for lifespans of] people in their 80s, [but] because people are dying in their 20s [and] 30s.”
The overall number of deaths across the U.S. totaled 2.8 million, or 69,255 more than in 2016, Erin Durkin notes for The Guardian. Of the top 10 leading causes of death—heart disease, cancer, unintentional injuries (drug overdoses constituted slightly less than half of this category in 2017), chronic lower respiratory disease, stroke, Alzheimer’s, diabetes, influenza and pneumonia, kidney disease, and suicide—only cancer witnessed a decrease in mortality rates. Seven, including suicide and unintentional injuries, experienced increases.
Josh Katz and Margot Sanger-Katz of The New York Times note that the rising number of overdose deaths corresponds with the growing use of synthetic opioids known as fentanyls. Deaths involving fentanyl increased more than 45 percent in 2017 alone, while deaths from legal painkillers remained stable from 2016 to 2017. To date, the overdose epidemic has wrought the most devastation in Northeast, Midwest and mid-Atlantic states.
Robert Anderson, chief of the Center for Health Statistics’ mortality branch, tells the Post’s Bernstein that the leveling off of prescription drug deaths may be the result of public health initiatives designed to curb the widespread availability and subsequent abuse of such medicines. Still, the rising prevalence of fentanyl, which is often mixed with heroin or falsely marketed as heroin, means the nation’s drug crisis is far from over.
In terms of deaths from suicide, Bernstein writes that there is a huge disparity between urban and rural Americans. The suicide rate amongst urban residents is 11.1 per 100,000 people, as opposed to rural residents’ 20 per 100,000. 
“Higher suicide rates in rural areas are due to nearly 60 percent of rural homes having a gun versus less than half of homes in urban areas,” psychiatrist and behavioral scientist Keith Humphreys of Stanford University says. “Having easily available lethal means is a big risk factor for suicide.”
Speaking with NPR, disease prevention expert William Dietz of George Washington University stressed the links between overdoses and suicides. Both may occur amongst people “less connected to each other in communities” and are tied to a “sense of hopelessness, which in turn could lead to an increase in rates of suicide and certainly addictive behaviors.”
McHugh echoes Dietz, concluding, “There's a tremendous amount of overlap between the two that isn't talked about nearly enough.”

‘The Numbers Are So Staggering.’
Overdose Deaths Set a Record Last Year.


by Josh Katz and Margot Sanger Katz - NYT - November 29, 2018

A class of synthetic drugs has replaced heroin in many major American drug markets, ushering in a more deadly phase of the opioid epidemic.
New numbers Thursday from the Centers for Disease Control and Prevention show that drug overdoses killed more than 70,000 Americans in 2017, a record. Overdose deaths are higher than deaths from H.I.V., car crashes or gun violenceat their peaks. The data also show that the increased deaths correspond strongly with the use of synthetic opioids known as fentanyls.
Since 2013, the number of overdose deaths associated with fentanyls and similar drugs has grown to more than 28,000, from 3,000. Deaths involving fentanyls increased more than 45 percent in 2017 alone.
“If we're talking about counting the bodies, where they lie, and the cause of death, we're talking about a fentanyls crisis,” said Jon Zibbell, a senior public health scientist at the research group RTI International.
The recent increases in drug overdose deaths have been so steep that they have contributed to reductions in the country’s life expectancy over the last three years, a pattern unprecedented since World War II. Life expectancy at birth has fallen by nearly four months, and drug overdoses are the leading cause of death for adults under 55.
“The idea that a developed wealthy nation like ours has declining life expectancy just doesn’t seem right,” said Robert Anderson, the chief of mortality statistics at the C.D.C., who helped prepare the reports. “If you look at the other wealthy countries of the world, they're not seeing the same thing.”
In a separate report, the C.D.C. also documented a 3.7 percent increase in the suicide rate, another continuation of a recent trend. The increases were particularly concentrated in rural America, and among middle-aged women, though the suicide rate for men remains higher than that for women at every age.
Recent federal public policy responses to the opioid epidemic have focused on opioid prescriptions. But several public health researchers say that the rise of fentanyls requires different tools. Opioid prescriptions have been falling, even as the death rates from overdoses are rising.
“Fentanyl deaths are up, a 45 percent increase; that is not a success,” said Dr. Dan Ciccarone, a professor of family and community medicine at the University of California, San Francisco. “We have a heroin and synthetic opioid epidemic that is out of control and needs to be addressed.”
Synthetic drugs tend to be more deadly than prescription pills and heroin for two main reasons. They are usually more potent, meaning small errors in measurement can lead to an overdose. The blends of synthetic drugs also tend to change frequently, making it easy for drug users to underestimate the strength of the drug they are injecting. In some parts of the country, drugs sold as heroin are exclusively fentanyls now.
Fentanyl’s contribution to the overdose death rate in selected states, 2015 to 201715overdose. The trends in overdose deaths vary widely across the country. The epidemic has been strongest in Northeast, Midwest and mid-Atlantic states. In the West, where heroin is much less likely to be mixed with fentanyls, overdose rates are far lower. Data from the C.D.C. indicate that a state’s overdose trend closely tracks the number of fentanyl-related deaths.
Despite the sharp recent increases in drug-related deaths, some early signs suggest that 2017 could be the peak of the overdose epidemic. Preliminary C.D.C. data show death rates leveling off nationally in the early months of this year, though there is still a lot of local variation. Several states and cities have embarked on ambitious public health programs to reduce the deadliness of drug use and connect more drug users with treatment, and some of those changes may be bearing fruit, for instance in Dayton, Ohio, where local officials have worked hard to push down the overdose rate. And in a ruling with implications for prisons and jails nationwide, a federal judge in Massachusetts this week ordered a jail to offer an addicted man access to methadone.
“What’s encouraging to me is that it’s sort of an all-hands-on-deck problem, and we’ve got all hands on deck,” said Anna Lembke, an associate professor of psychiatry at Stanford, and the author of a book on how medical practice contributed to the opioid epidemic.
But there is still a very long way to go. “The concept of a plateau doesn’t fill me with a lot of optimism, given how high the numbers are,” said Joshua Sharfstein, a vice dean at the Johns Hopkins Bloomberg School of Public Health, and the former secretary of health and mental hygiene in Maryland, where overdoses continue to rise. “The numbers are so staggering.”

With Beth Israel-Lahey merger, state charts new course on health care